Title: Translating Science Into Clinical Practice in Diabetes
1Translating Science Into Clinical Practice in
Diabetes
- Irene Heaston, MSN, RN
- Michelle Owens, PhD
- Magon M. Saunders, MS, RD, LD
- Centers for Disease Control and Prevention
- Division of Diabetes Translation
2Objectives
- Describe key results of landmark studies in
diabetes care and prevention - Discuss how this information impacts clinical
practice in managing patients with or at high
risk for diabetes - Discuss free resources from the National Diabetes
Education Program to help in patient education,
with a specific focus on African Americans.
3Background
- Diabetes costs over 174 billion annually
- Almost 24 million people in the United States
have diabetes - Another 57 million have pre-diabetes
4Racial and ethnic minorities are especially hard
hit by diabetes.
5Impact of Diabetes on African Americans
- Approximately 3.2 million or 13.3 of African
American aged 20 years or older have diabetes - For those born in 2000, 13 will develop diabetes
- African Americans are 1.8 times more likely to
have diabetes than Non- Hispanic Whites
6Diabetes Control andComplications Trial (DCCT)
- Compared effects of two diabetes treatment
regimens - standard therapy
- intensive control
- on the complications of diabetes
7DCCT Study Findings
- Glucose control is key to preventing or delaying
diabetes complications. - Any sustained lowering of blood glucose helps,
even if the person has a history of poor control.
8DCCT Study Findings
- Intensive lowering blood glucose reduced risk of
- Eye disease 76
- Kidney disease 50
- Nerve disease 60
9United Kingdom ProspectiveDiabetes Study (UKPDS)
- Clinical trial
- Looked at intensive management of blood glucose
levels and long-term risk factors for diabetes
complications
10UKPDS Findings
- Mirrored the findings of DCCT in
- people with type 2 diabetes
- Better glucose control
- Reduced development of microvascular
complications - Demonstrated the need for management of high
blood pressure and cholesterol as well - as blood glucose levels
11UKPDS Findings
- 1 decline in A1c provided the following risk
reduction - Microvascular diseases- 37
- Peripheral Vascular Disease- 43
- Myocardial Infarction -14 reduction
- Strokes- 12
- Heart Failure -10
- Cataract extractions- 19
12Diabetes Prevention Program (DPP)
- 27 clinical sites
- 3,234 subjects with IFG/IGT
- BMI gt 24
- 3 group randomized clinical trial
- 1 control group
- standard lifestyle modification
- 2 treatment groups
- metformin
- intensive lifestyle modification
13DPP Study Population
Asian 4
Caucasian 1768 African-American
645 Hispanic-American 508 Asian-American
142 Pacific Islander American Indian
171
American Indian 5
Hispanic American 16
African American 20
Caucasian 55
14Diabetes Prevention Program (DPP) Findings
- Lose 5 to 7 percent of body weight by
- Getting 30 minutes of physical activity,
- 5 days a week
- Following a low-fat, low-calorie eating plan
15DPP Lifestyle Intervention worked for
- All ethnic/racial groups
- Men and women, lean, plump or fat
- All adults, especially those over age 60
- There is special urgency for the high-risk!
16Discussion
- Based on the reviewed studies, it has been
confirmed that type 2 diabetes can be prevented
or delayed by clinical interventions.
17Translating Science into Action
- The National Diabetes Education Program (NDEP)
has successfully translated science into action,
by developing products and materials to raise
awareness about diabetes prevention and control.
18NDEP structure
- Partnership between two federal agencies, Centers
for Disease Control and Prevention and National
Institutes of Health, and over 200 partners - 59 State Diabetes Prevention and Control Programs
- Public and private organizations
- Traditional (e.g., American Diabetes Association)
and non-traditional - (National Urban League) partners
19Primary diabetes prevention
- The NDEP primary prevention campaign was
developed to raise awareness of the Diabetes
Prevention Program (DPP) results and translate
results into tools for people at high risk and
health care providers.
20High Risk Populations
21Focus group research with African Americans
- Fatalistic attitude that diabetes is inevitable
is common - Diabetes viewed by African Americans as less
serious than other health concerns (e.g., HIV,
cancer) - Many barriers to changing behavior around food
and physical activity
22Focus group recommendations
- Teach people how to lose weight and eat
healthfully - Messages should be simple, direct, tied to
consequence of having diabetes - Importance of family involvement and peer support
- Counter pessimism about being able to make
changes - Need options different things work for
different people - Address both people with diabetes and those at
risk
23African American/African Ancestry Workgroup
24African American/African Ancestry
25Now Available
26Power To Prevent A Family Lifestyle Approach to
Diabetes Prevention
- Community education intervention for the family
that focuses on - Physical activity
- Healthy eating, and
- Incorporates DPP results
- Uses existing tried-and-proven NDEP tools such as
the GAME PLAN toolkit materials (Fat and Calorie
Counter, Food and Activity Tracker)
27Curriculum organization
- Twelve 60-90 minute modules
- Suggestion modules once/week for 6 weeks then
once/month - Uses Adult Learning Theory
- Behavioral approach based on the DPP experience
- Use curriculum to guide small groups through
measuring, learning, practicing and maintaining
healthy behavior changes.
28Conclusions
- NDEP creates products and tools based on the
latest science on diabetes prevention and control
and from input received from focus group
participants - Pilot testing materials has aided NDEP in
understanding the needs of various populations
and in targeting specific groups - Innovative materials specifically designed to
reach African Americans will help health care
providers in providing patient education to this
population.
29- Visit the NDEPs Web sites
- www.ndep.nih.gov www.cdc.gov/diabetes/ndep
- www.diabetesatwork.org
- www.betterdiabetescare.nih.gov
- Call 1-800-438-5383
30Contact Information
- Irene Heaston
- 770-488-5062
- Iheaston_at_cdc.gov
- Michelle Owens-Gary, PhD
- 770-488-5014
- MOwens1_at_cdc.gov
- Magon Saunders, MS, RD, LD
- 770-488-5214
- MSaunders_at_cdc.gov